Dissociation of hippocampal serotonin release and locomotor activity following pharmacological manipulations of the median raphe nucleus

Behavioural Brain Research

Volumn 89, Issue 1-2, 1997, Pages 191-198

  Shim, Insop ^a   Javaid, J ^a   Wirtshafter, David ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

8 Hydroxy 2 (di n propylamino)tetralin; Baclofen; GABA; In vivo microdialysis; Locomotor activity; Median raphe nucleus; Muscimol; Serotonin

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; BACLOFEN; MUSCIMOL; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; HYPERACTIVITY; MALE; MEDIAN RAPHE NUCLEUS; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BACLOFEN; EXTRACELLULAR SPACE; GABA AGONISTS; HIPPOCAMPUS; HYDROXYINDOLEACETIC ACID; MALE; MICRODIALYSIS; MOTOR ACTIVITY; MUSCIMOL; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGONISTS;

EID: 0031422512     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(97)00060-0     Document Type: Article

References (54)

1. Adell A., Artigas F. Differential effects of clomipramine given locally or systemically on extracellular 5-HT in raphe nuclei and frontal cortex. An in vivo brain dialysis study. Naunyn Schmiedebergs Arch. Pharmacol. 343:1991;237-244.
2. Adell A., Carceller A., Artigas F. In vivo brain dialysis study of the somatodendritic release of serotonin in the raphe nuclei of the rat: Effects of 8-hydroxy-2-(Di-n-propylamino)tetralin. J. Neurochem. 60:1993;1673-1681.
3. Anden N.E., Dahlstrom A., Fuxe K., Larsson K., Olson L., Ungerstedt U. Ascending monoamine neurons to the telencephalon and diencephalon. Acta Physiol. Scand. 67:1966;313-326.
4. Asin K.E., Fibiger H.C. An analysis of neuronal elements within the median nucleus of the raphe that mediate lesion induced increases in locomotion. Brain Res. 268:1983;211.
5. Asin K.E., Wirtshafter D., Kent E.W. Straight alley acquisition and extinction and open field activity following discrete electrolytic lesions of the mesencephalic raphe nuclei. Behav. Neural Biol. 25:1979;242-256.
6. Auerbach S.B., Minzenberg M.J., Wilkinson L.O. Extracellular serotonin and 5hydroxyindoleacetic acid in hypothalamus of the unanesthetized rat measured by in vivo dialysis coupled to high-performance liquid chromatography with electrochemical detection: dialysate serotonin reflects neuronal release. Brain Res. 499:1989;281-290.
7. Belin M.F., Nanooulos D., Didier M., Aguera M., Steinbusch H., Verhofstad A., Maitre M., Pujol J.F. Immunohistochemical evidence for the presence of γ-aminobutyric acid and serotonin in one nerve cell. A study of the raphe nuclei using antibodies to glutamate dedarboxylase and serotonin. Brain Res. 275:1983;329-339.
8. Bel N., Artigas F. Fluvoxamine increases preferentially extracellular 5-hydroxytryptamine in the raphe nuclei: An in vivo microdialysis study. Eur. J. Pharmacol. 229:1992;101-113.
9. 1A agonist gepirone: Electrophysiological studies in the rat brain. Synapse. 1:1987;470-480.
10. Bonvento G., Scatton B., Claustre Y., Rouquier L. Effect of local injection of 8-OHDAPT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain. Neuroscience Lett. 132:1992;101-104.
11. Elliot P.J., Walsh D.M., Close S.P., Higgins G.A., Hayes A.G. Behavioral effects of serotonin agonists and antagonists in the rat and marmoset. Neuropharmarcology. 29:1990;949.
12. Forchetti C.M., Meek J.L. Evidence for a tonic GABAergic control of serotonin neurons in the median raphe nucleus. Brain Res. 206:1981;208-212.
13. Geyer M.A., Puerto A., Menkes D.B., Segal D.S., Mandell A.J. Behavioral studies following lesions of the mesolimbic and mesostriatal serotonergic pathways. Brain Res. 106:1976;257-270.
14. Grahame-Smith D.G. How important is the synthesis of brain 5-hydroxytryptamine in the physiological control of its central function? Adv. Biochem. Physiopharmacol. 10:1974;83-91.
15. Heybach J.P., Coover G.D., Lints C.E. Behavioral effects of neurotoxic lesions of the ascending monoamine pathways in the ret brain. J. Comp. Physiol. Psychol. 92:1978;58-70.
16. 1A agonist 8-OH-DPAT stimulates rat locomotor activity. Europ. J. Pharmacol. 160:1989;303.
17. Hillegaart V., Hjorth S., Ahlenius S. Effects of 5-HT and 8-OH-DPAT on forebrain monoamine synthesis after local application into the median and dorsal nuclei raphe of the rat. J. Neur. Transm. 81:1990;131-145.
18. Hole K., Fuxe K., Johnsson G. Behavioral effects of 5,7-dihydroxytryptamine lesions of ascending 5-hydroxytrypamine pathways. Brain Res. 107:1976;385-399.
19. Hole K., Johnson E., Berge O.G. 5,7-Dihydroxytryptamine lesions of the ascending 5-hydroxytryptamine pathways: Habituation, motor activity and agonistic behavior. Pharmacol. Biochem. Behav. 7:1977;205-210.
20. P.H. Hutson, C.T. Dourish, G. Curzon, 8-Hydroxy-2-(di-n-propylamino)tetralin (8OH-DPAT)-induced hyperphagia: Neurochemical and pharmacological evidence for an involvement of 5-hydroxythyptamine somatodendritic autoreceptors. In: C.T. Dourish, S. Ahlenius, P.H. Hutson (Eds.), Brain S-HTlA Receptors. Ellis Horwood, Chichester, UK, 1987.
21. Inverruzzi R., Carli M., Di Clemente A., Samanin R. Administration of 8-hydroxy-2(di-n-propylamino)tetralin in raphe nuclei dorsalis and medianus reduces serotonin synthesis in the rat brain: differences in potency and regional sensitivity. J. Neurochem. 56:1991;243-247.
22. Inverruzzi R., Belli S., Samanin R. Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Res. 584:1992;322-324.
23. Jacobs B.L., Cohen A. Differential behavioral effects of lesions of the median or dorsal raphe nuclei in rats: Open field and pain-elicited aggression. J. Comp. Physiol. Psychol. 90:1976;102-108.
24. A. Kalen, R.E. Strecker, E. Rosengren, A. Bjorklund, Endogenous release of neuronal serotonin and 5-HIAA in the caudate-putamen of the rat as revealed by intracerebral dialysis coupled to high performance liquid chromatography with fluorimetric detection. J. Neurochem., 51 (1988) 1422-1435.
25. Klitenick M.A., Wirtshafter D. Behavioral, biochemical and anatomical studies of opiates in the median raphe nucleus. J. Pharmacol. Exp. Ther. 273:1995;327-336.
26. Kohler C., Lorens S.A. Open field activity and avoidance behavior following serotonin depletion: A comparison of the effects of parachlorophenylalanine and electrolytic raphe lesions. Phamacol. Biochem. Behav. 8:1981;223-233.
27. Leger L., Wiklund L. Distribution and numbers of indoleamine cell bodies in the cat brainstem determined with the Falk-Hillarp fluorescence histochemistry. Brain Res. Bull. 9:1981;245-251.
28. Lorens S.A. Some behavioral effects of serotonin depletion depend on method: A comparison on 5,7-dihydroxytryptamine, p-chlorophenylalamine and electrolytic raphe lesions. Ann. NY Acad. Sci. 305:1978;532-555.
29. Mennini T., Gobbi M., Romandini S. Localization of GABA-A and GABA-B receptor subtypes on serotonergic neurons. Brain Res. 371:1986;372-375.
30. K.E. Moore, The anatomy of central serotonin neuron systems in the rat brain. in: B.L. Jacobs (Ed.), Serotonin Neurotransmission and Behavior, MIT Press, Cambridge, 1981.
31. Nishikawa T., Scatton B. Inhibitory influence of GABA on central serotoninergic transmission. Raphe nuclei as the neuroanatomical site of the GABAergic inhibition of cerebral serotonergic neurons. Brain Res. 331:1985;91-103.
32. Paris J., Lorens S.A. Intra-median raphe infusions of muscimol and the substance P analog DiMe-C7 produce hyperactivity: Role of serotonin neurons. Behav. Brain Res. 26:1987;139.
33. G. Paxinos and C. Watson, The rat brain in stereotaxic coordinates. Academic Press, New York (1986).
34. Sharp T., Bramwell S.R., Hjorth S., Graham-Smith D.G. Pharmacological charaterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis. J. Pharmacol. 98:1989;989-997.
35. Sharp T., Bramwell S.R., Clark D., Graham-Smith D.G. In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: Changes in relation to 5-hydroxytryptaminergic neuronal activity. J. Neurochem. 53:1989;234-240.
36. Sharp T., Bramwell S.R., Graham-Smith D.G. 5-HT agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br. J. Pharmacol. 96:1989;283-290.
37. Shim I., Wirtshafter D. Dissociation of hippocampal serotonin release and locomotor activity following drug injections into the median raphe nucleus. Soc. Neurosci. Abst. 21:1995;1694.
38. Shim I., Krebs J., Wirtshafter D. Effects of dopamine blockade on the hyperactivity produced by drug injections into the median raphe nucleus. Soc. Neurosci. Abst. 18:1992;1070.
39. Sneddon J.M. Blood platelets as a model for monoamine-containing neurons. Prog. Neurobiol. 1:1973;151-198.
40. Spampinato U., Esposito E., Romandini S., Samanin R. Changes of serotonin and dopamine metabolism in various forebrain areas of rats injected with morphine either systemically or in the raphe nuclei dorsalis and medianus. Brain Res. 328:1985;89-95.
41. 1B agonists. Synapse. 1:1987;3-9.
42. Tao R., Auerbach S.B. Involvement of dorsal raphe but not median raphe in morphine-induced increases in serotonin release in rat brain. Soc. Neurosci. Abstr. 19:1933;299.
43. 1A subtype. Eur. J. Pharmacol. 113:1985;463-464.
44. 1A binding sites on serotonin containing neurons in the raphe dorsalis and raphe centralis nuclei of the rat brain. Neurochem. Int. 7:1985;1061-1072.
45. Wirtshafter D., Asin K.E. Evidence that electrolytic median raphe lesions increase locomotion but not exploration. Physiol. Behav. 23:1979;409-410.
46. Wirtshafter D., Asin K.E., Kent E.W. Simple technique for midline stereotaxic surgery in the rat. Physiol. Behav. 23:1979;409-410.
47. Wirtshafter D., Klitenick M.A. Comparative studies of locomotor behavior following microinjections of muscimol into various sites in the pammedian tegmentum. Pharmacol. Biochem. Behav. 32:1989;625-628.
48. Wirtshafter D., Klitenick M.A., Asin K.E. Is dopamine involved in the hyperactivity produced by injections of muscimol into the median raphe nucleus. Pharmacol. Biochem. Behav. 27:1988;577-588.
49. Wirtshafter D., Klitenick M.A., Asin K.E. Evidence against serotonin involvement in the hyperactivity produced by injections of muscimol into the median raphe nucleus. Pharmacol. Biochem. Behav. 27:1987;45-52.
50. Wirtshafter D., Montana W., Asin K.E. Behavioral and biochemical studies of the substrates of median raphe lesion induced hyperactivity. Physiol. Behav. 38:1986;751-759.
51. Wirtshafter D., Stratford T.R., Pitzer M. Studies on the behavioral activation produced by stimulation of GABA-B receptors in the median raphe nucleus. Behav. Brain Res. 59:1993;83-93.
52. Wirtshafter D., Trifunovic R. Nonserotoninergic control of nucleus accumbens dopamine metabolism by the median raphe nucleus. Pharmacol. Biochem. Behav. 41:1992;501-505.
53. Wirtshafter D., Trifunovic R., Krebs J.C. Behavioral and a biochemical evidence for functional role of excitatory amino acids in the median raphe nucleus. Brain Res. 482:1989;225-234.
54. Wolf W.A., Youdim B.H., Kuhn D.M. Does brain 5-HIAA indicate serotonin release or monoamine oxidase activity? Eur. J. Pharmacol. 109:1985;381-387.